Triple-negative breast cancer (TNBC), which lacks the expression of the estrogen receptor (ER), progesterone receptor (PR), and excess amplification of human epidermal growth factor receptor 2 (HER2), is the most aggressive subtype of breast cancer18,19. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.